Market Review: April 20, 2026

Closing Recap

Monday, April 20, 2026

It was a quiet day on Wall Street for a change, with major averages trading in a tight and narrow range all afternoon as the S&P 500 and Nasdaq both snapped their 3 day streak of record closing highs and the Nasdaq snapped its winning streak at a whopping 13 days as renewed U.S.-Iran tensions threatened a ceasefire collapse and dented investor sentiment. Iran halted traffic through Hormuz less than 24 hours after saying ships could pass. Also, U.S. stocks sunk late morning after holding up the first hour of trading after President Donald Trump said it’s “highly unlikely” he would extend the two-week ceasefire with Iran if a deal is not reached before it ends and said the Strait of Hormuz would remain blocked until an agreement is finalized. President Trump noted VP Vance will leave for Pakistan later on Monday while the ceasefire expires Wednesday evening Washington time. The U.S. will host a second round of ambassador-level talks between Israel and Lebanon on Thursday at the State Department, according to officials from the two countries and an agency spokesperson. There was no economic data today while the Fed is in quiet period ahead of 4/29 FOMC. Markets awaited a busy week of upcoming earnings (GE, UNH, RTX, DHR, HAL, MMM, NOC, SYF, DHI tomorrow morning) before the floodgates open the next three weeks. Dow Transports surging another 3% to a fresh record high of 23,200, up 12 of the last 14 trading days with freight doing heavy lifting.

• June gold prices fell -$50.80 or 1.04% to settle at $4,828.80 an ounce.
• Bitcoin prices jumped this afternoon more than 2% to $76,400.
• The dollar index (DXY) was flat with no economic data or Fed speakers.
• Treasury yields also little changed on the day.

• In Footwear: Jefferies said analysis of US website traffic data for ONON suggests that the quality of traffic growth is increasingly below peers. ONON’s paid search share hit 77% vs peers at 26-48%, while organic traffic growth grew just 4% Y/Y in Mar after a 17% decline in Sept. Notably, ONON’s bounce rate rose to 50.3%, which is above peers and suggests that paid traffic is expensive and increasingly ineffective.
• In Food Sector: CALM shares were active after reports the U.S. Justice Department is preparing an antitrust suit against a few major egg producers, including Cal-Maine Foods and Versova, over alleged price coordination, the Wall Street Journal said on Friday. The Justice Department’s antitrust division is criminally investigating the conduct of large meatpackers (TSN, HRL, SFD, PPC) that supply American consumers, after President Trump called for a probe of the companies last year, according to people familiar with the matter – WSJ reported.

• European Energy: Barclays said on European energy services that it expects long-term implications to outweigh current uncertainties in the sector and lifts its price targets across the board. However, they downgrade five stocks while upgrading only two, based on their implied upsides in a sector that has been boosted by higher oil prices. Implications from the Middle East crisis include the need for inventories to be replenished and increasing demand for the services sector. Barclays upgrades Technip Energies (THNPF) and Viridien (VIRDY) to Overweight and cuts Subsea (SUBCY), SBM Offshore (SBFFF), Saipem (SAPMY) to EW from Overweight and Hunting (HNTIG) and Aker Solutions (AKRTF) to Underweight.
• In Pipeline & MLP sector: WMB and WBI upgraded to Buy from Neutral, TRP raised to Neutral and downgrade HESM to Sell (from Neutral) at Goldman Sachs saying look for solid nat gas demand driven by LNG capacity additions and behind-the-meter data center power demand, upside to Permian gas water availability, and a structurally improving LNG outlook, and lean into stocks with clear multiple compression to 2030

• Private Credit: OWL real assets division has agreed to acquire SILA, a healthcare-focused real estate investment trust, in an all-cash deal valued at about $2.4 billion, the companies said on Monday. Blue Owl will pay $30.38 per share for all the outstanding shares, a 19% premium to Sila’s closing price of $25.53 on April 17.

• In Research: Barclay’s double upgraded CLDX to Overweight from Underweight (PT to $45 rom $24) and downgraded both JANX to Underweight from Overweight (PT to $14 from $29) and TVRD to underweight from EW on SMID Biotech in Q1 preview.
• AGIO shares fell after rival NVO said its experimental once-daily oral pill etavopivat for sickle cell disease met the main goals of a late-stage trial; NVO said etavopivat showed superior reduction in pain and improvement in hemoglobin response in adults and adolescents with sickle cell disease.
• BIIB was upgraded to Overweight and raise PT to $250 from $200 as new revenue streams from immunology/kidney pipelines reduce reliance on neuro. Past the tau readout, we see attractive setup as multiple catalysts support clear path to growth.
• CMND shares jumped; announced that CMND-100, the Company’s proprietary non-hallucinogenic MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD) has met the primary endpoint in its FDA-approved Phase I/IIa clinical trial.
• GLSI said its experimental breast cancer vaccine shows stronger immune response; says the late-stage FLAMINGO 01 study tests GLSI 100, an experimental vaccine aimed at preventing breast cancer from coming back after standard treatment.
• LLY has agreed to buy privately held cancer biotech Kelonia Therapeutics for up to $7 billion in cash in a deal that bolsters the drugmaker’s genetic-medicine capabilities; LLY will make an upfront payment of $3.25 billion and subsequent payments upon the achievement of certain clinical, regulatory and commercial milestones.
• NKTR shares jumped after reported positive 52-week Phase 2b data for rezpegaldesleukin in severe alopecia areata. SALT ≤20 responses reached 25.8% and 27.6% in the treatment arms vs. 6.7% for placebo at week 52. The drug received FDA Fast Track status in 2025.
• NVO said its experimental oral drug, called etavopivat, reduced the risk of pain crises and improved hemoglobin response in patients with sickle cell disease, achieving the goals of a Phase 3 clinical trial.

• Healthcare Technology/IT: DOCS was downgraded to Hold from Buy at Truist in HCIT/Digital Health sector preview. Truist said at the company level, heading into Q1 earnings likes the setup for HNGE, WAY, ASTH, and PRVA. For DOCS Truist expects both FYQ426 results and FY27 guidance to be noisy, and as it has seen with other names in its coverage, once top-line growth visibility begins to fade, valuation support can quickly erode.

• In Building Products: BLD to be acquired by QXO in a transaction valued at about $17 billion. The deal has been approved by both companies’ boards and is expected to close in the third quarter of 2026, pending shareholder approval and other customary conditions.
• In Transports: CAR was downgraded to Underweight from Equal Weight at Barclays while raised tgt to $150 from $95 noting the shares were just $100 a month ago, and on Friday closed at nearly $500. Barclay’s attributes the rally to a sharp supply/demand mismatch, with two holders accounting for 71% of outright ownership of the company, and over 100% of economic interest given outstanding swaps (shares still rallied another 20% today to highs around $600). In airlines, AAL said it’s not engaged with or interested in any discussions regarding a merger with rival UAL. Bloomberg reported JBLU CEO says not considering bankruptcy in 2026; Bloomberg also reported Spirit Airlines has floated offering the US government an equity stake in the discount Carrier to help stave off its potential liquidation.
• In Satellite sector: ASTS shares tumbled after New Glenn rocket, launched by Jeff Bezos-owned Blue Origin on Sunday, failed to deploy ASTS satellite into correct orbit. The Satellite placed too low to sustain operations with its on-board thruster technology, will be de-orbited.

• In Rare Earth: USAR said to acquire Brazilian rare earths miner Serra Verde for $2.8 billion in cash and shares. The U.S. company will pay $300 million in cash and 126.9 million newly issued shares of its stock for the transaction, which is expected to close in the third quarter of 2026.
• In Metals & Mining: CLF Q1 adj EPS loss (-$0.40) vs. est. loss (-$0.42) on revs $4.9B vs. consensus $4.79B; reported adjusted EBITDA of $95M, impacted by $80M one-time energy cost from extreme cold weather; maintains 2026 steel shipment guidance at 16.5-17.0 mln net tons; expects 2026 capital expenditures of about $700M. Copper stocks slipped early with copper prices, down as the Strait of Hormuz closed to marine traffic once more and a fragile ceasefire between Iran and the U.S. looked in jeopardy, reigniting fears over growth.
• In Precious Metal miners: AEM will acquire all of the outstanding common shares of Rupert Resources (RUPRF) for about C$2.9 billion ($2.12 billion), the companies said on Monday; AEM will also acquire Aurion for about C$481 million in cash, offering C$2.60 per share, a premium of about 46% to the stock’s last close. Separately, the company will buy B2Gold’s 70% stake in the Fingold joint venture for $325 million.
• In Chemicals: Nitrogen fertilizer prices (CF), almost double what they were before the Iran war, may climb further as vital supplies remain locked up in the Persian Gulf, according to one of the world’s biggest exporters of the crop nutrient, per Bloomberg. ECL was upgraded to Buy, $325 as believes Ecolab’s early and aggressive price increases to offset higher energy prices due to the US-Iran conflict, coupled with the recent pullback in oil prices as the conflict winds down, has the potential to drive earnings upside in the back half of the year on widening price / cost differentials. WLK was downgraded to Hold at Deutsche bank, though raise tgt slightly to $120 as believes a sum-of the-parts analysis is best way to capture the value of Westlake’s portfolio.

• In Media: LGF was downgraded to Neutral from Buy at Citigroup saying the company may get acquired but the shares now reflect a meaningful takeout premium, and given its valuation, no longer views the stock’s risk/reward as compelling.
• In AI Data Center/Infrastruture sector: FRMI said its chief executive officer and chief financial officers have stepped down as the firm tries to secure its first customer. Stifel said this indicates that there was friction between customers and Mr. Neugebauer, and negotiations could be simpler going forward.

• Software: GTLB was downgraded to Sector Perform from Outperform at RBC Capital (tgt to $25 from $33) as believes short-term headwinds will likely keep the shares range bound. The headwinds include challenging Premium price increase compares, price-sensitive customer exposure, first order sales transition risks.
• Application Software: the WSJ reported ADBE is releasing a set of Ai agents that aim to help corporate customers automate digital marketing and other functions, the latest move by the software giant to stay ahead of Ai-driven software disruption. The product, called CX Enterprise, is an Ai agent-based platform that can be used to help businesses boost areas like customer Engagement, sales and loyalty, Adobe said.
• In Quantum: Northland initiated coverage in the quantum compute space with an Outperform and $20 tgt on QUBT, an Outperform and $55 tgt for IONQ and Market Perform ratings for both RGTI ($20 tgt) and QBTS ($22 tgt) saying Quantum computing’s market potential could be between $100B and $250B. The firm argues that investing across all quantum computing companies diversifies away the risk and assures participating in the asymmetrically positively skewed projected returns.

• NXPI was downgraded to Equal Weight at Wells Fargo and lower tgt to $235 from $265 as believes improving investor sentiment creates a tough setup into earnings for the analog semiconductor names. Wells cites a weaking auto backdrop for the downgrade of NXPI (said prefers ADI, MPWR) given DC-related exposure.
• PLXS was upgraded to Buy from Hold and raise PT to $250 from $200 at Stifel saying after two years of top-line headwinds, Stifel believes that the company has entered a multi-sector inflection driven by the convergence of share gains, program ramps, and improving end markets.
• Mizuho downgraded shares of both SWKS (tgt to $46 from $60) and QRVO (tgt to $66 from $70) to Underperform from Neutral with a price citing their supply chain checks and handset industry call for the downgrade. Handsets represent 60%-70% of revenue for Skyworks and Qorvo, and persistent memory shortages are compressing unit volumes and inflating average selling prices.